Tushar Patel

A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

Cholangiocarcinoma--controversies and challenges.

Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth.

miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

The role of microRNAs in human liver cancers.

Preneoplastic conditions underlying bile duct cancer.

Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Hepatic miR-29ab1 expression modulates chronic hepatic injury.

Non-coding RNAs as therapeutic targets in hepatocellular cancer.

microRNAs in liver disease: from diagnostics to therapeutics.

TIMP-1 attenuates blood-brain barrier permeability in mice with acute liver failure.

Isolation of extracellular nanovesicle microRNA from liver cancer cells in culture.

Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer.

New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma.

Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.

Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer.

Molecular evolution of genetic susceptibility to hepatocellular carcinoma.

Modulation of hypoxia-signaling pathways by extracellular linc-RoR.

Long noncoding RNA in liver diseases.

Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience.

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

Assessment of response to therapy in hepatocellular carcinoma.

Extracellular vesicle noncoding RNA: new players in the diagnosis and pathogenesis of cholangiocarcinoma.

Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.

Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy.

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.

Analysis of extracellular RNA by digital PCR.

Molecular diagnosis of intrahepatic cholangiocarcinoma.

Cholangiocarcinoma: molecular pathways and therapeutic opportunities.

EVpedia: a community web portal for extracellular vesicles research.

GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways.

Preexisting atrial fibrillation and cardiac complications after liver transplantation.

Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth.

Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity.

Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium.

Extracellular RNAs: development as biomarkers of human disease.

Educational Intervention in Primary Care Residents' Knowledge and Performance of Hepatitis B Vaccination in Patients with Diabetes Mellitus.

Development of an aptasensor for electrochemical detection of exosomes.

Microfluidic compartments with sensing microbeads for dynamic monitoring of cytokine and exosome release from single cells.

Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer.

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.

Plasma extracellular RNA profiles in healthy and cancer patients.

Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.

Predictors and impacts of hospital readmissions following liver transplantation.

Extending gene ontology in the context of extracellular RNA and vesicle communication.

 Giant cavernous hemangiomata of the liver: Watchful waiting, resection or transplantation?

Long non-coding RNA regulation of liver cancer stem cell self-renewal offers new therapeutic targeting opportunities.

Circulating Extracellular RNA Markers of Liver Regeneration.

In vitro toxicology studies of extracellular vesicles.

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.

MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.

Extracellular vesicles in liver diseases.

 Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.

BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.

Extracellular Vesicles from Bone Marrow-Derived Mesenchymal Stem Cells Improve Survival from Lethal Hepatic Failure in Mice.

Extracellular vesicles from bone marrow-derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury.

Investigation of Endocytic Pathways for the Internalization of Exosome-Associated Oligomeric Alpha-Synuclein.

Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center.

Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma.

A novel community driven software for functional enrichment analysis of extracellular vesicles data.

Radioembolization for hepatocellular carcinoma: The time has come.

Comparison of miRNA quantitation by Nanostring in serum and plasma samples.

Use of a Hollow Fiber Bioreactor to Collect Extracellular Vesicles from Cells in Culture.

Isolation of Extracellular RNA from Bile.

Droplet Digital PCR for Quantitation of Extracellular RNA.

Multiplexed Detection and Quantitation of Extracellular Vesicle RNA Expression Using NanoString.

Milk-derived Extracellular Vesicles for Therapeutic Delivery of Small Interfering RNAs.

Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.

Liver transplantation for intrahepatic cholangiocarcinoma.

Nanovesicle-mediated delivery of anticancer agents effectively induced cell death and regressed intrahepatic tumors in athymic mice.

Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma.

Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.

Therapeutic Efficacy of Vitamin D in Experimental c-MET-β-Catenin-Driven Hepatocellular Cancer.

Network analyses-based identification of circular ribonucleic acid-related pathways in intrahepatic cholangiocarcinoma.

Circulating Extracellular Vesicles in Human Disease.

Mesenchymal stem cell derived extracellular vesicles: a promising new therapeutic approach for hepatic injury.

Large Differences in Small RNA Composition Between Human Biofluids.

Circulating Extracellular Vesicles in Human Disease.

Early Detection of Hepatocellular Carcinoma: Expanding the Utility of Circulating Tumor Markers.

Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma.

The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research.

Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation.

exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids.

Extracellular Vesicle-Based Therapeutic Targeting of β-Catenin to Modulate Anticancer Immune Responses in Hepatocellular Cancer.

Clinical diagnosis and management of intrahepatic cholangiocarcinoma.

Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center.

Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes.

Predictors and impacts of hospital readmissions following liver transplantation.

Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma.

The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease.